No Data Available
Vista Pharmaceuticals Share Price
| Open | - |
| High | - |
| Low | - |
| Prev Close | - |
| Volume | - |
| VWAP(₹) | - |
Key Metrics
| PE Ratio(x) | -3.84 |
| EPS - TTM(₹) | -1.96 |
| MCap(₹ Cr.) | 46.29 |
| MCap Rank | 155 |
| PB Ratio(x) | 1.25 |
| Div Yield(%) | - |
| Face Value(₹) | 2.00 |
| 52W High(₹) | 11.87 |
| 52W Low(₹) | 5.71 |
| MCap/Sales | 6.97 |
| Beta(1 Month) | 0.70 |
| BV/Share(₹) | 5.92 |
Vista Pharma share price insights
Losing Shareholder's Money
Company has reported a negative ROE for 3 consecutive years. (Source: Standalone Financials)PAT: Troublesome Times
Company has posted a loss of Rs 5.86 cr for the 4th consecutive quarter. (Source: Standalone Financials)Employee & Interest Expense
Company has spent 20.39% of its operating revenues towards interest expenses and 40.73% towards employee cost in the year ending Mar 31, 2026. (Source: Standalone Financials)Vista Pharma Share Price Update
Vista Pharmaceuticals Ltd. share price moved up by 1.62% from its previous close of Rs 7.40. Vista Pharmaceuticals Ltd. stock last traded price is 7.52
Share Price Value Today/Current/Last 7.52 Previous Day 7.40
Found Insights useful?
Vista Pharma Share Price Returns
| 1 Day | 1.62% |
| 1 Month | 3.01% |
| 3 Months | 1.48% |
| 1 Year | -32.37% |
| 3 Years | -25.54% |
| 5 Years | -41.48% |
Vista Pharma Share Recommendations
No Recommendations details available for this stock.
Check out other stock recos.
News & Analysis
Financials
Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Total Income 0.03 2.51 1.65 1.52 3.47 Total Income Growth (%) -98.69 51.55 8.97 -56.24 29.65 Total Expenses 7.25 5.61 5.10 2.81 4.33 Total Expenses Growth (%) 29.19 10.03 81.74 -35.15 1.59 EBIT -7.22 -3.10 -3.44 -1.29 -0.86 EBIT Growth (%) - - - - - Profit after Tax (PAT) -5.86 -2.32 -2.59 -1.29 -1.50 PAT Growth (%) - - - - - EBIT Margin (%) 0.00 -123.72 -208.13 -84.75 -24.66 Net Profit Margin (%) 0.00 -92.48 -156.42 -84.97 -43.09 Basic EPS (₹) -0.91 -0.41 -0.42 -0.22 -0.79 All figures in Rs Cr, unless mentioned otherwise
InsightsPAT: Troublesome Times
Company has posted a loss of Rs 5.86 cr for the 4th consecutive quarter. (Source: Standalone Financials)Employee & Interest Expense
Company has spent 20.39% of its operating revenues towards interest expenses and 40.73% towards employee cost in the year ending Mar 31, 2026. (Source: Standalone Financials)
Annual FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 Total Assets 55.08 60.29 57.98 56.03 55.59 Total Assets Growth (%) -8.64 3.98 3.48 0.79 9.32 Total Liabilities 18.64 14.87 17.52 19.32 20.14 Total Liabilities Growth (%) 25.35 -15.13 -9.32 -4.07 11.83 Total Equity 36.44 45.42 40.46 36.71 35.45 Total Equity Growth (%) -19.77 12.26 10.22 3.55 7.91 Current Ratio (x) 0.92 1.19 1.61 1.69 1.43 Total Debt to Equity (x) 0.27 0.16 0.20 0.27 0.35 Contingent Liabilities 0.00 - - - - All figures in Rs Cr, unless mentioned otherwise
Annual FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 Net Cash flow from Operating Activities -4.40 -6.98 -4.91 -1.71 -0.99 Net Cash used in Investing Activities -0.78 -0.44 -0.79 -1.27 -0.01 Net Cash flow from Financing Activities 4.56 8.06 5.59 3.11 0.94 Net Cash Flow -0.63 0.64 -0.11 0.13 -0.07 Closing Cash & Cash Equivalent 0.11 0.73 0.09 0.20 0.07 Closing Cash & Cash Equivalent Growth (%) -85.41 675.98 -53.68 183.33 -48.57 Total Debt/ CFO (x) -2.27 -1.06 -1.62 -5.82 -12.64 All figures in Rs Cr, unless mentioned otherwise
InsightsIncrease in Cash from Investing
Company has used Rs 0.78 cr for investing activities which is an YoY increase of 77.75%. (Source: Standalone Financials)
Annual FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 Return on Equity (%) -33.09 -10.23 -11.15 -15.42 -2.34 Return on Capital Employed (%) -39.15 -9.02 -9.10 -11.11 -3.70 Return on Assets (%) -21.89 -7.71 -7.78 -10.10 -1.49 Interest Coverage Ratio (x) -12.99 -3.72 -2.65 -3.33 -1.16 Asset Turnover Ratio (x) 0.09 0.17 0.18 0.02 0.01 Price to Earnings (x) -3.12 -14.22 -11.15 -5.55 -40.82 Price to Book (x) 1.03 1.46 1.24 0.86 0.96 EV/EBITDA (x) -3.32 -20.29 -17.96 -10.17 -44.41 EBITDA Margin (%) -264.86 -35.61 -31.47 -403.02 -264.79 InsightsLosing Shareholder's Money
Company has reported a negative ROE for 3 consecutive years. (Source: Standalone Financials)
Found Financials useful?
Technicals
No Data Available
R1 - Pivot -
S1 - R2 - S2 - R3 - S3 - 5 Days 14 Days 28 Days - - -
Peer Comparison
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Choose from Peers
Choose from Stocks
Mutual Funds Ownership
No Data Available
Vista Pharma Top Searches
Corporate Actions
Board Meeting
Audited Results
May 19, 2026
Board Meeting
Quarterly Results
Feb 05, 2026
Board Meeting
Quarterly Results
Nov 04, 2025
Announced on Meeting on May 19, 2026 May 29, 2026 Audited Results Feb 05, 2026 Feb 13, 2026 Quarterly Results Nov 04, 2025 Nov 13, 2025 Quarterly Results Aug 06, 2025 Aug 13, 2025 Quarterly Results May 20, 2025 May 30, 2025 Audited Results No Data Available
No Data Available
No Data Available
No Data Available
Announced on Meeting on Sep 15, 2025 Sep 30, 2025 - Feb 25, 2025 Mar 20, 2025 - Sep 19, 2024 Sep 30, 2024 A.G.M. Sep 06, 2023 Sep 30, 2023 - Aug 13, 2022 Sep 29, 2022 -
About Vista Pharma
Vista Pharmaceuticals Ltd., incorporated in the year 1991, is a Small Cap company (having a market cap of Rs 46.29 Crore) operating in Pharmaceuticals sector.
Industry
Key Indices Listed On
-
Address
Plot Nos. 10 to 14 and 16 to 20,TSIIC Industrial Estate,Narketpalli Mandal,Nalgonda District, Telangana - 508254
Executive Leadership
Dhananjaya Alli
Chairman & Wholetime DirectorMurali Meraga
Managing DirectorPavan Sathvik Gilaka
Whole Time DirectorDivakar Reddy Yerrabommanahalli
Non Executive DirectorAuditors
FAQs about Vista Pharma share
- 1. What's the Vista Pharma share price today?Vista Pharma share price is Rs 7.52 as on 17 Jun, 2026, 03:40 PM IST. Vista Pharma share price is up by 1.62% based on previous share price of Rs. 7.22.
- 2. What has been highest price of Vista Pharma share in last 52 weeks?52 Week high of Vista Pharma share is Rs 11.87 while 52 week low is Rs 5.71
- 3. What's the market capitalization of Vista Pharma?Vista Pharma share has a market capitalization of Rs 46.29 Cr. Within Pharmaceuticals sector, it's market cap rank is 155.
- 4. What is the PE & PB ratio of Vista Pharma?The PE ratio of Vista Pharma stands at -3.78, while the PB ratio is 1.25.
- 5. What are the returns for Vista Pharma share?Return Performance of Vista Pharma Shares:
- 1 Week: Vista Pharma share price moved up by 2.17%
Top Gainers
As on 03:59 PM | 17 Jun 2026Top Losers
As on 03:59 PM | 17 Jun 2026Trending in Markets
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.